Sumatriptan Succinate
NDC Package 49884-482-99
Package Information
Sumatriptan Succinate is sumatriptan is used to treat migraines. Marketed by Par Pharmaceutical Inc, this product is identified by NDC 49884-482 and is authorized under FDA application NDA020080.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 49884 - Par Pharmaceutical Inc
- 49884-482 - Sumatriptan Succinate
- 49884-482-99 - 2 SYRINGE in 1 PACKAGE / .5 mL in 1 SYRINGE
- 49884-482 - Sumatriptan Succinate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (49884-482). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 49884-482-99 identifies a specific commercial package of 2 syringe in 1 package / .5 ml in 1 syringe of Sumatriptan Succinate, labeled by Par Pharmaceutical Inc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Par Pharmaceutical Inc on July 22, 2008. The current certification is valid through October 05, 2013.
What are the primary indications for this medication?
Sumatriptan is used to treat migraines. It helps to relieve headache, pain, and other migraine symptoms (including nausea, vomiting, sensitivity to light/sound). Prompt treatment helps you return to your normal routine and may decrease your need for other pain medications. Sumatriptan belongs to a class of drugs known as triptans. It affects a certain natural substance (serotonin) that causes narrowing of blood vessels in the brain. It may also relieve pain by affecting certain nerves in the brain. Sumatriptan does not prevent future migraines or lessen how often you get migraine attacks.
How is this Par Pharmaceutical Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 49884048299. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.